AVORO CAPITAL ADVISORS LLC
AVORO CAPITAL ADVISORS LLC runs AVORO CAPITAL ADVISORS LLC and currently holds 26 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $11.14B. Their top holdings are UTHR, KRYS, MDGL, ARGX, ARWR. The top five represent 48.6% of reported portfolio weight. AVORO CAPITAL ADVISORS LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, AVORO CAPITAL ADVISORS LLC initiated 1 new position. They added to 9 existing positions. They trimmed 2 positions. Their current best-performing preview position is QURE with returns of +181.71%.
26 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
UTHR UNITED THERAPEUTICS CORP | 13.52% | $248.82 | $513.12 | +106.22% | Added +5.62% |
KRYS KRYSTAL BIOTECH INC | 9.64% | $105.41 | $346.58 | +228.79% | Held |
MDGL MADRIGAL PHARMACEUTICALS INC | 8.84% | $176.98 | $516.74 | +191.98% | Added +0.83% |
ARGX ARGENX SE | 8.33% | $194.05 | $1,039.78 | +435.83% | Held |
ARWR ARROWHEAD PHARMACEUTICALS INC | 8.31% | $30.23 | $87.11 | +188.16% | Added +6.13% |
KYMR KYMERA THERAPEUTICS INC | 7.70% | $39.16 | $119.80 | +205.92% | Held |
RVMD REVOLUTION MEDICINES INC | 3.86% | $80.96 | $209.46 | +158.72% | Trimmed -2.02% |
CYTK CYTOKINETICS INC | 3.82% | $72.34 | $76.84 | +6.22% | Added +50.00% |
CELC CELCUITY INC | 3.19% | $100.89 | $93.53 | -7.30% | Added +0.74% |
XENE XENON PHARMACEUTICALS INC | 3.13% | $23.84 | $60.77 | +154.91% | Held |
Showing 1-10 of 26